Skip to main content

Table 4 Echocardiographic parameters according to tertiles of circulating DPP4 activity in diabetic patients

From: The activity of circulating dipeptidyl peptidase-4 is associated with subclinical left ventricular dysfunction in patients with type 2 diabetes mellitus

Parameters

DPP4 (pmol/min/mL)

p value

<5060

5060-6208

>6208

LV Morphology

    

LVEDVindex (mL/m2)

63.7 ± 13

66.4 ± 12

63.9 ± 17

0.794

LVESVindex (mL/m2)

20.8 ± 6.6

22.9 ± 9.5

25.4 ± 7.7

0.080

IVSTd (mm)

10 (9-12)

11(9-13)

10 (9-12)

0.450

PWTd (mm)

10 (9-12)

11 (10-12)

11 (9.3-12)

0.095

RWT

0.42 ± 0.06

0.46 ± 0.05

0.42 ± 0.09

0.086

Prevalence of LV concentric geometry (n, %)

15, 55

20, 71

14, 50

0.128

LVM/BSA (g/m2)

94.6 (81-132)

112 (94.6-134)

110 (84-131)

0.201

Prevalence of LVH (n, %)

10, 37

16, 57

11, 40

0.294

Observed/predicted LVM (%)

124 ± 27.9

132 ± 25.4

134 ± 30.6

0.535

Prevalence of inappropriate LVM (n, %)

13, 48

16, 57

14, 50

0.932

LA Morphology

    

LA long-axis (cm)

5.4 ± 0.7

5.1 ± 0.9

5.3 ± 0.8

0.443

LA minor-axis (cm)

4 ± 0.7

3.7 ± 0.7

3.9 ± 0.8

0.605

LA ap (cm)

3.8 ± 0.6

3.5 ± 0.9

3.8 ± 0.9

0.424

LA volume index (mL/m2)

20.3 (16-29.3)

17 (14.7-23.7)

20.7 (13.2-33)

0.450

Prevalence of LA enlargement (n,%)

7, 26

4, 14

8, 29

0.442

  1. LV means left ventricular; LVEDVi, LV end-diastolic volume index; LVESVi, LV end-systolic volume index; IVSTd, interventricular septum thickness in diastole; PWTd, posterior wall thickness in diastole; RWT, relative wall thickness; LVM, LV mass; BSA, body surface area; LVH, left ventricular hypertrophy; LA, left atrial. Values are expressed as mean ± SD or median (interquartile range), and categorical variables as numbers and percentages.